rs3895063

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000319006.8(TALDO1):​c.98-220G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.09 in 611,260 control chromosomes in the GnomAD database, including 2,838 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.077 ( 556 hom., cov: 31)
Exomes 𝑓: 0.094 ( 2282 hom. )

Consequence

TALDO1
ENST00000319006.8 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.23

Publications

20 publications found
Variant links:
Genes affected
TALDO1 (HGNC:11559): (transaldolase 1) Transaldolase 1 is a key enzyme of the nonoxidative pentose phosphate pathway providing ribose-5-phosphate for nucleic acid synthesis and NADPH for lipid biosynthesis. This pathway can also maintain glutathione at a reduced state and thus protect sulfhydryl groups and cellular integrity from oxygen radicals. The functional gene of transaldolase 1 is located on chromosome 11 and a pseudogene is identified on chromosome 1 but there are conflicting map locations. The second and third exon of this gene were developed by insertion of a retrotransposable element. This gene is thought to be involved in multiple sclerosis. [provided by RefSeq, Jul 2008]
TALDO1 Gene-Disease associations (from GenCC):
  • transaldolase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.107 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000319006.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TALDO1
NM_006755.2
MANE Select
c.98-220G>A
intron
N/ANP_006746.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TALDO1
ENST00000319006.8
TSL:1 MANE Select
c.98-220G>A
intron
N/AENSP00000321259.3
TALDO1
ENST00000528097.5
TSL:1
c.98-220G>A
intron
N/AENSP00000437098.1
TALDO1
ENST00000528070.5
TSL:5
n.*155-220G>A
intron
N/AENSP00000435042.1

Frequencies

GnomAD3 genomes
AF:
0.0771
AC:
11725
AN:
152094
Hom.:
558
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0231
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.0922
Gnomad ASJ
AF:
0.0548
Gnomad EAS
AF:
0.0604
Gnomad SAS
AF:
0.0738
Gnomad FIN
AF:
0.0850
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.109
Gnomad OTH
AF:
0.0718
GnomAD4 exome
AF:
0.0943
AC:
43305
AN:
459048
Hom.:
2282
AF XY:
0.0931
AC XY:
22546
AN XY:
242240
show subpopulations
African (AFR)
AF:
0.0211
AC:
277
AN:
13156
American (AMR)
AF:
0.0815
AC:
2027
AN:
24878
Ashkenazi Jewish (ASJ)
AF:
0.0626
AC:
876
AN:
13992
East Asian (EAS)
AF:
0.0653
AC:
1814
AN:
27800
South Asian (SAS)
AF:
0.0714
AC:
3551
AN:
49742
European-Finnish (FIN)
AF:
0.0880
AC:
2213
AN:
25146
Middle Eastern (MID)
AF:
0.0483
AC:
93
AN:
1926
European-Non Finnish (NFE)
AF:
0.109
AC:
30194
AN:
276948
Other (OTH)
AF:
0.0888
AC:
2260
AN:
25460
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2030
4060
6089
8119
10149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0771
AC:
11728
AN:
152212
Hom.:
556
Cov.:
31
AF XY:
0.0757
AC XY:
5632
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0230
AC:
956
AN:
41556
American (AMR)
AF:
0.0920
AC:
1405
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0548
AC:
190
AN:
3468
East Asian (EAS)
AF:
0.0605
AC:
314
AN:
5188
South Asian (SAS)
AF:
0.0731
AC:
352
AN:
4818
European-Finnish (FIN)
AF:
0.0850
AC:
899
AN:
10582
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.109
AC:
7412
AN:
68004
Other (OTH)
AF:
0.0772
AC:
163
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
559
1118
1678
2237
2796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0951
Hom.:
1323
Bravo
AF:
0.0738
Asia WGS
AF:
0.0910
AC:
314
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.14
DANN
Benign
0.58
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3895063; hg19: chr11-755659; API